Keywords: topotarget, loss, grows, costs, danish, drugmaker, says

TopoTarget's loss grows 282%, on R&D costs

Article | 26 March 2007

Print This

Danish drugmaker TopoTarget AS says that R&D costs were partially responsible for the increase in its loss for 2006 which, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in